Articles
-
Watch VideoLeading Causes: Interrogating the “Why” Behind Health Inequity in Cancer Care
How do social determinants of health impact outcomes in cancer care? New Century Health Associate CMO Dr. Monica Soni and Radiation Oncologist Dr. Onyinye Balogun discuss.
-
Read ArticleBridging the Gaps in Advance Care Planning in Oncology
New Century Health and our Vital Decisions solution seek to ensure more cancer patients receive end-of-life care that aligns with their wishes.
-
Read Press ReleaseNew Century Health Partner Cancer Care Specialists of Illinois Earns $3.6 Million from Medicare through Federal Oncology Care Model
NCH’s high-value clinical oncology pathways, patient triage programs and provider engagement strategies help community practice to succeed in value-based payment program.
-
Read ArticleStill Bracing for the Surge in Advanced Cancer Cases
The predicted wave of late-stage cancers is taking longer to materialize than we expected.
-
Read ArticleCancer Moonshot 2.0: Three Big Questions to Track
Which components of the recently announced Cancer Moonshot should get high priority for the initiative to succeed? Our chief medical officer, Dr. Andrew Hertler, outlines three key questions to track.
-
Watch VideoDeveloping a playbook to tackle health inequities in cancer care
New Century Health Associate Chief Medical Officer Monica Soni explores health inequities in cancer cares and shares strategies for how to address them.
-
Read External ArticleAccelerated Drug Approvals Present a Mounting Challenge to Oncologists
Dr. Andrew Hertler explains three key criteria for evaluating fast-tracked drugs.
-
Watch VideoA Plea for Better Endings
Confronting the heart-wrenching, avoidable circumstances that happen in hospitals and homes every day.
-
Read ArticlePatient Impact Story: Clinical Review Catches Potential Medical Error
Red flags cause clinical reviewers to question a radiation oncologist’s diagnosis.
-
Watch VideoPanel Discussion: Oncology Care Reimagined
Health plan clinical leaders joined us for an insightful discussion on the path toward high-value cancer care.
-
Read External ArticleLocation, Location, Location. That Also Applies to Cancer Treatment.
Home-based chemotherapy infusions may offer convenience but also raise a host of questions.
-
Read ArticleShouldering the Burden and Financial Toxicity of Part D Cancer Drugs
Discussing drug costs should be a core tenet of shared decision-making.
-
Read Press ReleaseNew Century Health Parent Company Elects Dr. Tunde Sotunde To Board Of Directors
Sotunde is president and CEO of Blue Cross and Blue Shield of North Carolina.
-
Read Press ReleaseNew Century Health to Support Health New England With Comprehensive Advance Care Planning Services
Partnership will empower members with serious illness to articulate and advocate for the care they want.
-
Read External ArticleSpecialty Therapies Offering Incremental Benefit Shouldn’t Be Added to Clinical Pathways, Hertler Says
Evidence-Based Oncology interviews our CMO about mismatches between drug costs and efficacy.
-
Read External ArticleThe Mainstreaming of Targeted Lung Cancer Treatment
Our CMO speaks with Managed Care Executive about the promise and perils of genomic testing.
-
Read ArticleHealth Systems' Rare Rejection of Alzheimer's Drug Sparks Questions About FDA Approvals
Modern Healthcare spoke with NCH's Dr. Andrew Hertler about problems in the FDA's approval process.
-
Read ArticleSpecialty Pharmacies Grapple with Assessing Costs and Value of Oncology Therapies
Our CMO speaks with Formulary Watch about the challenges of high--cost drugs with marginal benefit.
-
Read ArticleEvolent Health, Parent Company of New Century Health, Announces Agreement to Acquire Vital Decisions
The addition of Vital Decisions’ specialized patient engagement services expected to position New Century Health to accelerate growth, improve patient care quality and increase margins.
-
Read ArticleHitting the Brakes on Fast-Tracked Drugs
The FDA's Aduhelm approval was highly controversial, but not as surprising for those who follow the oncology drug pipeline.
-
Loading More...
